Journal article · 2024 · Open access

Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021

Michael D Brauer, Gregory A. Roth, Aleksandr Y. Aravkin, Peng Zheng, Kalkidan Hassen Abate, Yohannes Habtegiorgis Abate, Cristiana Abbafati, Rouzbeh Abbasgholizadeh, Madineh Akram Abbasi, Mohammadreza Abbasian, Mitra Abbasifard, Mohsen Abbasi‐Kangevari and 1,783 more

The Lancet, 403(10440), 2162–2203 · Published 1 May 2024 · DOI 10.1016/s0140-6736(24)00933-4

Read the free full textCite this paper

In brief

“Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021” is a 2024 journal article by Michael D Brauer and 1,794 co-authors, published in The Lancet. OpenAlex counts 3,471 citations as of 15 November 2026. It is open access under a CC BY licence: the full text is free to read at The Lancet.

Citations
3,471
Most cited in
2025 (1,708)
Field-weighted impact
913.51
References
94
Authors
1,795

Abstract

BACKGROUND: Understanding the health consequences associated with exposure to risk factors is necessary to inform public health policy and practice. To systematically quantify the contributions of risk factor exposures to specific health outcomes, the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2021 aims to provide comprehensive estimates of exposure levels, relative health risks, and attributable burden of disease for 88 risk factors in 204 countries and territories and 811 subnational locations, from 1990 to 2021. METHODS: The GBD 2021 risk factor analysis used data from 54 561 total distinct sources to produce epidemiological estimates for 88 risk factors and their associated health outcomes for a total of 631 risk-outcome pairs. Pairs were included on the basis of data-driven determination of a risk-outcome association. Age-sex-location-year-specific estimates were generated at global, regional, and national levels. Our approach followed the comparative risk assessment framework predicated on a causal web of hierarchically organised, potentially combinative, modifiable risks. Relative risks (RRs) of a given outcome occurring as a function of risk factor exposure were estimated separately for each risk-outcome pair, and summary exposure values (SEVs), representing risk-weighted exposure prevalence, and theoretical minimum risk exposure levels (TMRELs) were estimated for each risk factor. These estimates were used to calculate the population attributable fraction (PAF; ie, the proportional change in health risk that would occur if exposure to a risk factor were reduced to the TMREL). The product of PAFs and disease burden associated with a given outcome, measured in disability-adjusted life-years (DALYs), yielded measures of attributable burden (ie, the proportion of total disease burden attributable to a particular risk factor or combination of risk factors). Adjustments for mediation were applied to account for relationships involving risk factors that act indirectly on outcomes via intermediate risks. Attributable burden estimates were stratified by Socio-demographic Index (SDI) quintile and presented as counts, age-standardised rates, and rankings. To complement estimates of RR and attributable burden, newly developed burden of proof risk function (BPRF) methods were applied to yield supplementary, conservative interpretations of risk-outcome associations based on the consistency of underlying evidence, accounting for unexplained heterogeneity between input data from different studies. Estimates reported represent the mean value across 500 draws from the estimate's distribution, with 95% uncertainty intervals (UIs) calculated as the 2·5th and 97·5th percentile values across the draws. FINDINGS: Among the specific risk factors analysed for this study, particulate matter air pollution was the leading contributor to the global disease burden in 2021, contributing 8·0% (95% UI 6·7-9·4) of total DALYs, followed by high systolic…

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Brauer, M. D., Roth, G. A., Aravkin, A. Y., Zheng, P., Abate, K. H., Abate, Y. H., Abbafati, C., Abbasgholizadeh, R., Abbasi, M. A., Abbasian, M., Abbasifard, M., Abbasi‐Kangevari, M., ElHafeez, S. A., Abd-Elsalam, S. M., Abdi, P., Abdollahi, M. R., Abdoun, M., Abdulah, D. M., Abdullahi, A., . . . Gakidou, E. E. (2024). Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021. The Lancet, 403(10440), 2162–2203. https://doi.org/10.1016/s0140-6736(24)00933-4

MLA 9

Brauer, Michael D, et al. “Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021.” The Lancet, vol. 403, no. 10440, 2024, pp. 2162–2203. https://doi.org/10.1016/s0140-6736(24)00933-4.

Chicago

Brauer, Michael D, Gregory A. Roth, Aleksandr Y. Aravkin, Peng Zheng, Kalkidan Hassen Abate, Yohannes Habtegiorgis Abate, Cristiana Abbafati, et al. 2024. “Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021.” The Lancet 403 (10440): 2162–2203. https://doi.org/10.1016/s0140-6736(24)00933-4.

Harvard

Brauer, M. D. et al. (2024) ‘Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021’, The Lancet, 403(10440), pp. 2162–2203. doi:10.1016/s0140-6736(24)00933-4.

IEEE

M. D. Brauer et al., “Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021,” The Lancet, vol. 403, no. 10440, pp. 2162–2203, 2024, doi: 10.1016/s0140-6736(24)00933-4.

BibTeX

@article{brauer2024global,
  title     = {{Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021}},
  author    = {Brauer, Michael D and Roth, Gregory A. and Aravkin, Aleksandr Y. and Zheng, Peng and Abate, Kalkidan Hassen and Abate, Yohannes Habtegiorgis and Abbafati, Cristiana and Abbasgholizadeh, Rouzbeh and Abbasi, Madineh Akram and Abbasian, Mohammadreza and Abbasifard, Mitra and Abbasi‐Kangevari, Mohsen and ElHafeez, Samar Abd and Abd-Elsalam, Sherief Mohamed and Abdi, Parsa and Abdollahi, Mohammad Reza and Abdoun, Meriem and Abdulah, Deldar Morad and Abdullahi, Auwal and Abebe, Mesfin and Abedi, Aidin and Abedi, Armita and Abegaz, Tadesse Melaku and Zúñiga, Roberto Ariel Abeldaño and Abiodun, Olumide A and Abiso, Temesgen Lera and Aboagye, Richard Gyan and Abolhassani, Hassan and Abouzid, Mohamed and Aboye, Girma Beressa and others},
  journal   = {The Lancet},
  year      = {2024},
  volume    = {403},
  number    = {10440},
  pages     = {2162--2203},
  doi       = {10.1016/s0140-6736(24)00933-4},
  url       = {https://doi.org/10.1016/s0140-6736(24)00933-4}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
201611
202011
2024310310
20251,7081708
20261,4511451

Its field-weighted citation impact is 913.51: it has been cited 913.51 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Risk Factors

  • risk factors
  • attributable burden
  • relative risk
  • population attributable fraction
  • disability-adjusted life years
  • socio-demographic index
  • health risk exposure
  • disease burden

Work with this paper

Most-cited papers in Medicine

All highly cited Medicine papers

Questions about this paper

How do I cite this paper in APA style?

Brauer, M. D., Roth, G. A., Aravkin, A. Y., Zheng, P., Abate, K. H., Abate, Y. H., Abbafati, C., Abbasgholizadeh, R., Abbasi, M. A., Abbasian, M., Abbasifard, M., Abbasi‐Kangevari, M., ElHafeez, S. A., Abd-Elsalam, S. M., Abdi, P., Abdollahi, M. R., Abdoun, M., Abdulah, D. M., Abdullahi, A., . . . Gakidou, E. E. (2024). Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021. The Lancet, 403(10440), 2162–2203. https://doi.org/10.1016/s0140-6736(24)00933-4

How many times has this paper been cited?

3,471 times, according to OpenAlex on 15 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access: read the free full text at The Lancet.

Who wrote this paper?

Michael D Brauer, Gregory A. Roth, Aleksandr Y. Aravkin, Peng Zheng, Kalkidan Hassen Abate, Yohannes Habtegiorgis Abate, Cristiana Abbafati, Rouzbeh Abbasgholizadeh, Madineh Akram Abbasi, Mohammadreza Abbasian, Mitra Abbasifard, Mohsen Abbasi‐Kangevari and 1,783 more.

What is the DOI of this paper?

10.1016/s0140-6736(24)00933-4. The permanent link is https://doi.org/10.1016/s0140-6736(24)00933-4.

Bibliographic data from OpenAlex (CC0), last checked 15 November 2026. ResearchGuru does not host this paper; the links go to the publisher or the repository that does.